Becker's Healthcare September 26, 2019
Consumer genetics company 23andMe is partnering with TrialSpark to help accelerate the pace, quality and experience of clinical trials, according to STAT.
The company plans to help match its customers with nearby study sites based on their disease, demographics and DNA.
The partnership comes as 23andMe moves into drug development, mining its database for therapeutic targets and entering research partnerships with drugmakers, universities and other nonprofits.
...